The term biophotonics denotes a combination of biology and photonics, with photonics being the science and technology of generation, manipulation, and detection of photons, quantum units of light. Photonics is related to electronics and photons. Photons play a central role in information technologies such as fiber optics the way electrons do in electronics. Biophotonics can also be described as the "development and application of optical techniques, particularly imaging, to the study of biological molecules, cells and tissue". One of the main benefits of using optical techniques which make up biophotonics is that they preserve the integrity of the biological cells being examined.
The worldwide biophotonics market is expected to witness a significant growth in the future, due to the rising old age population, along with the increasing incidence of chronic diseases. The other factors include, increasing use of biophotonics in cell and tissue diagnostics, emergence of nanotechnology in biophotonics, and development of novel photoacoustic tomography (PAT) system. The Asia Pacific biophotonics market is expected to grow at a CAGR exceeding 13% over the next few years. Due to the augmented investment in R&D activities, coupled with the increasing prevalence of cancer, the market is expected to witness a substantial growth. The increasing healthcare expenditure and rising government initiatives are expected to fuel the demand for the regional market.

Market Analysis and Insights: Global Biophotonics Market
The global Biophotonics market size is projected to reach US$ 55560 million by 2027, from US$ 35530 million in 2020, at a CAGR of 6.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biophotonics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biophotonics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biophotonics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biophotonics market.

Global Biophotonics Scope and Market Size
Biophotonics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biophotonics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
In-Vivo
In-Vitro

Segment by Application
See-Through Imaging
Inside Imaging
Spectromolecular
Surface Imaging
Microscopy
Light Therapy
Biosensors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Carl Zeiss
Olympus
Hamamatsu Photonics
EndraLife Sciences
HORIBA
Newport
PerkinElmer
TILL Photonics
Zecotek Photonics